Methotrexate Therapy in Obstetrica? Diseases

Authors

  • Aneta Tomescu
  • Rodica Sirbu Ovidius University of Constanta, Faculty of Pharmacy, Constanta, Romania
  • Stelian Paris Ovidius University of Constanta, Faculty of Pharmacy, Constanta, Romania
  • Emin Cadar UMF Carol Davila Bucharest, Faculty of Pharmacy, Bucharest, Romania
  • Cristina-Luiza Erimia Ovidius University of Constanta, Faculty of Pharmacy, Constanta, Romania
  • Cezar Laurentiu Tomescu Ovidius University of Constanta, Faculty of Medicine, Constanta, Romania

DOI:

https://doi.org/10.26417/ejis.v4i1.p9-16

Keywords:

Methotrexate, obstetrics, gynecology, tubal pregnancy, HCG human chorionic gonadotrophine hormon.

Abstract

Our study is a rewiew of Methotrexate therapy in obstetrica? diseases such us: hydatidiform mole, and medical abortion. In the medical world, methotrexate is a citostatic drug used in neoplastic diseases. The clinical pharmacology data regarding methotrexate is presented, alongside route of administration and therapeutic effects in malignant disease, hydatiform mole, and medical abortion. The use of methotrexate in medical abortion and ectopic pregnancy is a great accomplishment, as it replaces a surgical intervention marred by characteristic side effects, with similar results.

Downloads

Published

2020-09-15

Issue

Vol. 3 No. 2 (2020): July -December 2020

Section

Articles

License

Copyright (c) 2020 European Journal of Natural Sciences and Medicine

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

How to Cite

Methotrexate Therapy in Obstetrica? Diseases. (2020). European Journal of Medicine and Natural Sciences, 3(2), 43-49. https://doi.org/10.26417/ejis.v4i1.p9-16